FIELD: pharmaceutical chemistry.
SUBSTANCE: invention describes a method of producing dexmedetomidine and its pharmaceutically acceptable salts. Technical problem solved by the invention consists in the development of the most waste-free and cheap method for synthesis of dexmedetomidine. Result is achieved due to preliminary enrichment of medetomidine with S-enantiomer at early stages of synthesis, by effective method of regeneration of “chiral wastes”, as well as separating amine.
EFFECT: higher efficiency due to increased degree of dexmedetomidine extraction from racemic mixture.
3 cl, 2 dwg, 2 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING MEDETOMIDINE AND DERIVATIVES | 2022 |
|
RU2791397C1 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2597364C2 |
BI-ARYL-META-PYRIMIDINE KINASE INHIBITORS | 2006 |
|
RU2589878C2 |
BENZOTHIA(DI)AZEPINES AND THEIR USE AS BILE ACID MODULATORS | 2019 |
|
RU2785867C2 |
HYBRID DERIVATIVES OF (1H-1,2,4) TRIAZOLE AND SULPHUR-CONTAINING HETEROCYCLES: DERIVATIVES OF THIAZOLIDINE-2,4-DIONE, THIOMORPHOLINE-3-ONE, AND 1,4-THIAZEPAN-3-ONE, EXHIBITING ANTIMICROBIAL ACTIVITY | 2020 |
|
RU2771027C1 |
CYCLIC CYANOENONE DERIVATIVES AS KEAP1 MODULATORS | 2021 |
|
RU2822828C1 |
METHOD OF PRODUCING SOFOSBUVIR AND PHOSPHORAMIDATES | 2020 |
|
RU2740058C1 |
GLP-1 RECEPTOR AGONISTS AND USE THEREOF | 2019 |
|
RU2769715C1 |
SUBSTITUTED 3,4,12,12A-TETRAHYDRO-1H-[1,4]OXAZINO[3,4-C]PYRIDO[2,1-F][1,2,4]TRIAZINE-6,8-DIONE, PHARMACEUTICAL COMPOSITION, METHODS FOR PRODUCTION AND USE THEREOF | 2019 |
|
RU2720305C1 |
METHODS OF FORMING GLYCOSIDE BONDS, CHEMICAL COMPOSITION, GLYCOSIDE AND GLYCOSIDE LIBRARY | 1994 |
|
RU2134693C1 |
Authors
Dates
2024-08-19—Published
2023-12-20—Filed